42 Scientific services, namely, development of pharmaceutical treatments for psychiatric and neurological conditions; scientific research services into medicinal preparations for the treatment of psychiatric and neurological conditions such as depression, major depressive disorder, treatment-resistant depression, anxiety, substance misuse disorders, alcohol use disorder, bipolar disorder, post-traumatic stress disorder, and eating disorders; provision of information relating to the research, development and use of medicinal preparations for the treatment of psychiatric and neurological conditions, such as depression, major depressive disorder, treatment-resistant depression, anxiety, substance misuse disorders, alcohol use disorder, bipolar disorder, post-traumatic stress disorder, and eating disorders; scientific advisory and consultancy services relating to the treatment of psychiatric and neurological conditions, and the research, development and use of medicinal preparations for the treatment of psychiatric and neurological conditions